Front-of-package labels have spurred companies in other countries to cut sugars and salt. The FDA wants to follow suit here.

January 15, 2025 Check out STAT+

Sponsored By

Tim Boyle/Getty Images How the FDA's new nutrition labels could prod the food industry to get healthier FDA proposes new nutrition labels on front of packaged foods. Research shows such labels spurred some manufacturers toward healthier options. By Sarah Todd STAT+ | At JPM, biotech industry expresses excitement — and some anxiety — about therapies from China As American venture capital rushes to cash in on Chinese biotech deals, execs worry about China's rapid growth: "Folks there are good at moving quickly." By Allison DeAngelis FDA bans red dye No. 3 in foods, decades after additive found to cause cancer in rats Manufacturers have until 2027 to reformulate products. Potential health risks of the artificial food color have been debated for decades. By Lizzy Lawrence and Sarah Todd AP Opinion: The infamous 'Cutter vaccine' changed my family forever — but we still support vaccination "All that science can do is mitigate risks, not eradicate them," Laurie Maffly-Kipp writes. That includes vaccines. By Laurie Maffly-Kipp STAT+ | As health insurers flee JPM, Alignment Healthcare decides to stay Only one other insurer — Clover Health, another Medicare Advantage company that is only half the size of Alignment — is at the conference. By Bob Herman FDA proposes nicotine limits on tobacco products to make them less addictive "Single greatest positive impact on public health in the history of public health," says one researcher, but the nicotine rule is not final. By Sarah Todd and Lizzy Lawrence Adobe Could inhaling xenon gas help treat Alzheimer's? A new mouse study suggests it might Study in Science Translational Medicine was conducted in mice. Phase 1 clinical trial is recruiting patients, set to start this year By Anil Oza Eli Lilly CEO on Trump, obesity drugs, and a guidance miss Eli Lilly CEO Dave Ricks joins us to discuss Trump's upcoming term, pricing of the obesity drug Zepbound, and a sales guidance miss. By Elaine Chen, Allison DeAngelis, and Adam Feuerstein STAT+ | Health AI investments are off to a roaring start in 2025 Over the last week, digital health startups with an AI focus have announced impressive fundraises, setting the tone for the rest of 2025. By Mario Aguilar

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser